News and Announcements
A high-level event in Cape Town, South Africa, on 2 December 2014 will celebrate the launch of the second programme of the European & Developing Countries Clinical Trials Partnership (EDCTP2).Read more » News, Announcements'
The results of REMoxTB, a phase III global clinical trial of new tuberculosis drug regimens, were published in the New England Journal of Medicine. The trial was led by Prof. Stephen H. Gillespie (St. Andrews University, Scotland) and conducted mainl...Read more » Announcements, News'
The diagnosis of paediatric tuberculosis is marred with difficulty, mainly due to the challenge in collecting sputum samples. A European & Developing Countries Clinical Trials-funded project (TB CHILD) has developed a new immunodiagnostic tool TAM-...Read more » News, Announcements'
The combination of a boosted protease inhibitor (lopinavir) with two nucleoside reverse-transcriptase inhibitors (NRTIs) is a feasible second-line therapy for HIV patients in Africa. These are the results of the EDCTP-funded EARNEST trial, coordinate...Read more »
Challenges in Malaria Research: Core science and innovation
22 September 2014
Third Global Symposium on Health Systems Research
30 September 2014
HIV Research for Prevention 2014 (HIV R4P)
28 October 2014
EDCTP Stakeholder meetings